Aevi Genomic Medicine, Inc. Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31)
Aevi Genomic Medicine, Inc. reported Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) of 2139.15% for the 12-month period ending 2007-12-31, per its 10-K filed 2013-03-14.
Discontinued › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio · last filed 2013-03-14
- Aevi Genomic Medicine, Inc. stockholders' equity note, stock split, conversion ratio (deprecated 2013-01-31) for fiscal 2007 was 2139.15%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) 12 month |
|---|---|
| 2007-12-31 | 2139.15% 10-K · filed 2013-03-14 |